High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies

Autor:	Joël Gozlan, Nancy Stella Cuervo, Aurélie Schnuriger, Narjis Boukli, Laurence Morand-Joubert, Melchior Le Mene, Cécilia Laroche
Rok vydání:	2020
Předmět:	serological tests 0301 basic medicine Microbiology (medical) viruses 030106 microbiology coronavirus Disease medicine.disease_cause Serology 03 medical and health sciences 0302 clinical medicine Immune system antibodies Medicine 030212 general & internal medicine skin and connective tissue diseases Letter to the Editor Coronavirus biology medicine.diagnostic_test Liaison SARS-CoV-2 business.industry fungi COVID-19 virus diseases biochemical phenomena metabolism and nutrition biology.organism_classification Virology Immunoassay biology.protein Antibody business Betacoronavirus
Zdroj:	Journal of Clinical Microbiology
ISSN:	1098-660X 0095-1137
DOI:	10.1128/jcm.01352-20
Popis:	Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major pandemic ([1][1]). Diagnosis is based on detection of viral RNA, whereas the immune response to SARS-CoV-2 is measured by serological tests which detect antibodies (Abs) directed
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b9850fc3b336f00d89990ecc2adf93f https://doi.org/10.1128/jcm.01352-20 Zobrazit plný text záznamu